Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

• Status: Recruiting
• Trial end date: 2021-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

Prevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a directly observed complete therapy, to prevent of maternal anaemia and fetal growth restriction. The investigators will compare this intervention with usual care in a multicentre randomised trial.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Services Institute of Medical Sciences, Pakistan
• Collaborators: Allama Iqbal Medical College; Universidad de Granada
• Treatments: Iron

Criteria

Inclusion Criteria:

• Non-anaemic iron deficiency

Exclusion Criteria:

• Anaemia or normal iron stores